Reviva Pharmaceuticals Holdings Inc. Gains 18.88%
Mon, Oct 10, 2022 at 07:01 PM
Reviva Pharmaceuticals Holdings Inc. (RVPH:NASDAQ) rocketted at $2.77, representing a gain of 18.9%. On Mon, Oct 10, 2022, RVPH:NASDAQ touched a New 2-Week High of $2.77. The stock appeared on our News Catalysts scanner on Mon, Sep 26, 2022 at 06:42 AM in the 'MISCELLANEOUS' category. From Mon, Sep 26, 2022, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Mon, Aug 29, 2022 at $3.1 with a volume of 34M+.
About Reviva Pharmaceuticals Holdings Inc. (RVPH:NASDAQ)
Reviva Pharmaceuticals Holdings Inc is a clinical-stage biopharmaceutical company.
Top 10 Gainers:
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 70.97%
- Immunic, Inc. (IMUX:NASDAQ), 56.57%
- Green Giant Inc Com (New) (GGE:NASDAQ), 39.26%
- Intelligent Living Application Group Inc. (ILAG:NASDAQ), 29.65%
- Concord Medical Services Holdings Limited (CCM:NYSE), 22.22%
- Universe Pharmaceuticals Inc (UPC:NASDAQ), 21.95%
- AEA-Bridges Impact Corp. Class A (IMPX:NYSE), 20.69%
- Recon Technology, Ltd. (RCON:NASDAQ), 19.88%
- Terran Orbital Corporation (LLAP:NYSE), 19.49%
- Reviva Pharmaceuticals Holdings Inc. (RVPH:NASDAQ), 18.88%